{"title":"Is drug-use stigma a breach of human rights law?: Insights from Australia","authors":"Sean Mulcahy , Kate Seear , Carla Treloar","doi":"10.1016/j.drugpo.2025.104902","DOIUrl":null,"url":null,"abstract":"<div><div>Whilst international drug policy increasingly recognises the need to address drug-use stigma, there is limited consideration of how drug-use stigma can be addressed through legal frameworks. This commentary considers the relationship between drug-use stigma and human rights law that prohibits torture and cruel, inhuman, or degrading treatment. In doing so, this commentary examines a landmark Australian coronial case that raised the possibility that stigma may constitute a form of cruel, inhuman, and degrading treatment and therefore is unlawful due to its incompatibility with human rights law. This framing carries potential implications for the legality of stigma in Australia and other jurisdictions that prohibit torture and cruel, inhuman, or degrading treatment. Human rights frameworks could underpin legal claims against stigmatising treatment of people who use drugs. Establishing a sound legal basis for the claim that drug-use stigma is unlawful could also compel legal authorities, including courts and legislatures, to adopt legal decisions and statutes that do not stigmatise people who use drugs and thusly move away from the criminalisation and carceralisation of drug use. Further evolution and testing of these arguments are needed to harness the possibilities of Australian and international law to address drug-use stigma.</div></div>","PeriodicalId":48364,"journal":{"name":"International Journal of Drug Policy","volume":"143 ","pages":"Article 104902"},"PeriodicalIF":4.4000,"publicationDate":"2025-06-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"International Journal of Drug Policy","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0955395925002026","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"SUBSTANCE ABUSE","Score":null,"Total":0}
引用次数: 0
Abstract
Whilst international drug policy increasingly recognises the need to address drug-use stigma, there is limited consideration of how drug-use stigma can be addressed through legal frameworks. This commentary considers the relationship between drug-use stigma and human rights law that prohibits torture and cruel, inhuman, or degrading treatment. In doing so, this commentary examines a landmark Australian coronial case that raised the possibility that stigma may constitute a form of cruel, inhuman, and degrading treatment and therefore is unlawful due to its incompatibility with human rights law. This framing carries potential implications for the legality of stigma in Australia and other jurisdictions that prohibit torture and cruel, inhuman, or degrading treatment. Human rights frameworks could underpin legal claims against stigmatising treatment of people who use drugs. Establishing a sound legal basis for the claim that drug-use stigma is unlawful could also compel legal authorities, including courts and legislatures, to adopt legal decisions and statutes that do not stigmatise people who use drugs and thusly move away from the criminalisation and carceralisation of drug use. Further evolution and testing of these arguments are needed to harness the possibilities of Australian and international law to address drug-use stigma.
期刊介绍:
The International Journal of Drug Policy provides a forum for the dissemination of current research, reviews, debate, and critical analysis on drug use and drug policy in a global context. It seeks to publish material on the social, political, legal, and health contexts of psychoactive substance use, both licit and illicit. The journal is particularly concerned to explore the effects of drug policy and practice on drug-using behaviour and its health and social consequences. It is the policy of the journal to represent a wide range of material on drug-related matters from around the world.